[go: up one dir, main page]

AU2003299096A1 - Novel angiogenesis target and uses thereof - Google Patents

Novel angiogenesis target and uses thereof

Info

Publication number
AU2003299096A1
AU2003299096A1 AU2003299096A AU2003299096A AU2003299096A1 AU 2003299096 A1 AU2003299096 A1 AU 2003299096A1 AU 2003299096 A AU2003299096 A AU 2003299096A AU 2003299096 A AU2003299096 A AU 2003299096A AU 2003299096 A1 AU2003299096 A1 AU 2003299096A1
Authority
AU
Australia
Prior art keywords
novel angiogenesis
angiogenesis target
target
novel
angiogenesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003299096A
Other versions
AU2003299096A8 (en
Inventor
Silvere Petit
Fabien Schweighoffer
Emmanuel Valentin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExonHit Therapeutics SA
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Publication of AU2003299096A8 publication Critical patent/AU2003299096A8/en
Publication of AU2003299096A1 publication Critical patent/AU2003299096A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Cell Biology (AREA)
  • Cardiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AU2003299096A 2002-09-25 2003-09-24 Novel angiogenesis target and uses thereof Abandoned AU2003299096A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0211853A FR2844713A1 (en) 2002-09-25 2002-09-25 Use of inhibitor of FLJ protein, for treatment and prevention of e.g. cancer, diabetic retinopathy or arthritis, also new protein, nucleic acid and their inhibitors
FR02/11853 2002-09-25
PCT/FR2003/002810 WO2004029089A2 (en) 2002-09-25 2003-09-24 Novel angiogenesis target and uses thereof

Publications (2)

Publication Number Publication Date
AU2003299096A8 AU2003299096A8 (en) 2004-04-19
AU2003299096A1 true AU2003299096A1 (en) 2004-04-19

Family

ID=31970980

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003299096A Abandoned AU2003299096A1 (en) 2002-09-25 2003-09-24 Novel angiogenesis target and uses thereof

Country Status (3)

Country Link
AU (1) AU2003299096A1 (en)
FR (1) FR2844713A1 (en)
WO (1) WO2004029089A2 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2775984B1 (en) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa QUALITATIVE DIFFERENTIAL SCREENING
WO2001029221A2 (en) * 1999-10-20 2001-04-26 Zymogenetics, Inc. Proteins and polynucleotides encoding them
AU2001274888A1 (en) * 2000-05-19 2001-12-03 Human Genome Sciences, Inc. Nucleic acids, proteins, and antibodies
MXPA03001468A (en) * 2000-08-15 2004-05-04 Immunex Corp Claudin polypeptides.
CA2421056A1 (en) * 2000-09-01 2002-03-28 Genentech, Inc. A polypeptide for use as a diagnostic marker for the presence of colon tumours
US6783969B1 (en) * 2001-03-05 2004-08-31 Nuvelo, Inc. Cathepsin V-like polypeptides
ATE483976T1 (en) * 2001-06-05 2010-10-15 Exelixis Inc GFATS AS P53 PATHWAY MODIFIERS AND METHODS OF USE

Also Published As

Publication number Publication date
AU2003299096A8 (en) 2004-04-19
FR2844713A1 (en) 2004-03-26
WO2004029089A2 (en) 2004-04-08
WO2004029089A3 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
AU2002315389A1 (en) Novel pyrazolo-and pyrrolo-pyrimidines and uses thereof
AU2002367404A1 (en) Redox-switchable materials
AU2002305523A1 (en) Dioxanes and uses thereof
AU2002315388A1 (en) Novel phenylamino-pyrimidines and uses thereof
AU2003243594A1 (en) Novel boronic chalcone derivatives and uses thereof
EP1646834A1 (en) Condensor
AUPS110302A0 (en) Novel chalcone derivatives and uses thereof
AU2003248957A1 (en) Feruloyl esterase and uses thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AU2002257430A1 (en) Androgen-mediated neuroprotection and uses thereof
AU2003214857A1 (en) Syndecans and angiogenesis
AU2003214391A1 (en) Recombinant spores
AU2003246971A1 (en) Tranquilliser dart
AU2003278334A1 (en) Material
AU2003299096A1 (en) Novel angiogenesis target and uses thereof
AU2003300859A1 (en) Carrier-ligand fusions and uses thereof
AU2002950855A0 (en) Materials
AU2003228397A1 (en) HAUSP-p53 INTERACTION AND USES THEREOF
AU2003219313A1 (en) Chemokines and uses thereof
AUPS243002A0 (en) Therapeutic target and uses thereof
AU2003216442A1 (en) Enkurin and uses thereof
AU2003300656A1 (en) Novel angiogenic molecular target and uses thereof
AU2003269002A1 (en) Novel building material
AU2003299520A1 (en) Urocortin-deficient mice and uses thereof
AU2003213936A1 (en) Polypeptides from bacteria and uses thereof

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase